For example, filaggrin mutations are only present in a small percentage of AD patients [65,66], disease onset may not depend on it [67] and alteration of lipid processing enzymes are not correlated with presence of FLG mutation [9]. This evidence concerns the gene FLG and Alzheimer disease.